← back to search

Adam R. Brentnall

Queen Mary University of London · GB
Area of research
Oncology · Genetics
Research interest
Research interests include Global Cancer Incidence and Screening, BRCA gene mutations in cancer, Digital Radiography and Breast Imaging, and Cancer Risks and Factors.
h-index
41
citations
5,631
works
204
NIH funding
primary concept
email

Recent publications

Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention
JAMA Oncology 2025cited by 5position: middledoi
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer
JAMA Network Open 2025cited by 4position: middledoi
Health-Related Quality Of Life After Risk-Reducing Hysterectomy: A Cross-Sectional Study Of Women With Lynch Syndrome
International Journal of Gynecological Cancer 2025cited by 1position: middledoi
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
JAMA Network Open 2024cited by 18position: middledoi
Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort
International Journal of Cancer 2024cited by 14position: middledoi
Penetrance estimates of hereditary cancers in a population setting using UK Biobank data
BJC Reports 2024cited by 2position: lastdoi
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis
American Journal of Obstetrics and Gynecology 2023cited by 29position: middledoi
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK
Cancers 2023cited by 3position: middledoi
Errors in determination of net survival: cause-specific and relative survival settings
British Journal of Cancer 2020cited by 34position: middledoi
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
JAMA Oncology 2019cited by 139position: middledoi
Genome-wide association study of germline variants and breast cancer-specific mortality
British Journal of Cancer 2019cited by 73position: middledoi
66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
International Journal of Gynecological Cancer 2019cited by 4position: middledoi
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
The American Journal of Human Genetics 2018cited by 1,166position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ranjit Manchanda · All India Institute of Medical Sciences Bhubaneswar8 papers (2019–2025)Rosa Legood · London School of Hygiene & Tropical Medicine6 papers (2019–2025)Stephen W. Duffy · University of Pittsburgh Medical Center5 papers (2019–2025)Ashwin Kalra · Queen Mary University of London5 papers (2023–2025)Samuel Oxley · University of London5 papers (2023–2025)Michail Sideris · University of London5 papers (2023–2025)D. Gareth Evans · Translational Research Institute4 papers (2019–2025)Wei Xia · London School of Hygiene & Tropical Medicine4 papers (2023–2025)Li Sun · London School of Hygiene & Tropical Medicine4 papers (2019–2025)Li Yang · Hebei Medical University4 papers (2019–2025)Caitlin T. Fierheller · McGill University Health Centre3 papers (2024–2025)Jack Cuzick · Jenner Institute3 papers (2019–2024) · 3 papers (2024–2025)Shuai Li · BGI Group (China)2 papers (2019–2019)Diana Eccles · Southampton General Hospital2 papers (2019–2019) · 2 papers (2025–2025)Isabel dos‐Santos‐Silva · London School of Hygiene & Tropical Medicine2 papers (2019–2019)Zia Sadique · University of Balochistan2 papers (2019–2019)Shreeya Patel · The University of Texas Health Science Center at Houston2 papers (2019–2019)John L. Hopper · National Institute on Deafness and Other Communication Disorders2 papers (2019–2019)